ThinkGenetic Blog

News from ThinkGenetic

  • Home
  • SymptomMatcher
  • Disease Knowledge Base
  • News
  • About Us
  • Contact Us
Browse Diseases

Is all cancer genetic? Understanding hereditary risk

July 15, 2019 Guest Author Leave a Comment

Bottom Story - Cancer Genetics - ThinkGenetic

Editor’s Note: I am so thrilled that my colleague and friend, Jennifer Propst, is able to share her genetic cancer expertise with all of us through this piece. It can… CONTINUE

Filed Under: Advocacy, Education Tagged With: BRCA1, BRCA2, breast cancer, cancer, cancer diagnosis, carcinogens, coordinate testing, FDA, genetic counselor, genetic testing, hereditary cancer, hereditary predisposition to cancer, hereditary risk, increased risk, Lynch syndrome, MSH2, ovarian cancer, pancreatic cancer, prostastic cancer, somatic genetic testing, tumor DNA, tumor DNA profiling, tumor DNA sequencing

It’s Amazing What a Person’s Face Can’t Tell You

November 8, 2017 Georgia Loucopoulos, Genetic Counseling Student Intern Leave a Comment

  ‘I can read you like a book.’ I’ve never actually said this to anyone, but sometimes it’s true. As a first-year genetic counseling student, I’ve had many opportunities to… CONTINUE

Filed Under: Education Tagged With: BRCA1, BRCA2, genetic counseling, genetic counseling student, genetic counselor, Georgia Loucopoulos

ThinkGenetic Collaborates with Sharsheret to Support Jewish Women Facing Breast and Ovarian Cancer

September 12, 2017 Len Barker Leave a Comment

Sharsheret, a national not-for-profit organization supporting young Jewish women and their families facing breast and ovarian cancer, has joined ThinkGenetic’s Advocacy Partner program. Sharsheret, Hebrew for “chain,” is the only… CONTINUE

Filed Under: Partners Tagged With: Adina Fleischmann, advocacy partner, Ashkenazi Jewish, BRCA1, BRCA2, breast cancer, Breast Cancer Awareness, herditary cancer, Len Barker, ovarian cancer, Ovarian Cancer Awareness, Sephardic Jewish, Sharsheret

ThinkGenetic Welcomes Bright Pink to Its Advocacy Partner Program

August 9, 2017 Len Barker Leave a Comment

Bright Pink®, a U.S.-based non-profit organization focused on prevention and early detection of breast and ovarian cancer in young women, has become the newest member of ThinkGenetic’s growing Advocacy Partner… CONTINUE

Filed Under: Partners Tagged With: BRCA1, BRCA2, breast cancer, Bright Pink, ovarian cancer

Search the News & Press

Connect with Us

     
  • Home
  • News
  • About Us
  • Contact Us
  • Sponsor / Advertise
  • Disclaimers
  • Terms and Conditions
  • Privacy Policy
©2021 ThinkGenetic. All Rights Reserved.ThinkGenetic does not provide medical advice, diagnosis or treatment. Click here for more information.

Copyright © 2021 · Genesis Framework · WordPress · Log in